RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+33.9%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.54B
AUM Growth
+$1.54B
Cap. Flow
+$136M
Cap. Flow %
8.81%
Top 10 Hldgs %
73.5%
Holding
35
New
4
Increased
4
Reduced
1
Closed
8

Top Buys

1
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
$75.7M
2
IMMU
Immunomedics Inc
IMMU
$73.8M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
$48.2M
4
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
$44M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
$24.4M

Top Sells

1
AVXS
AveXis, Inc. Common Stock
AVXS
$127M
2
GYRE icon
Gyre Therapeutics
GYRE
$13.3M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$9.37M
4
VKTX icon
Viking Therapeutics
VKTX
$8.87M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$6.72M

Sector Composition

1 Healthcare 92.08%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.53B
$287M 18.66% 7,512,049 – –
ASND icon
2
Ascendis Pharma
ASND
$11.8B
$282M 18.31% 4,240,536 – –
SLDB icon
3
Solid Biosciences
SLDB
$427M
$95.8M 6.22% 2,689,444 – –
ECYT
4
DELISTED
Endocyte, Inc. Common Stock
ECYT
$78M 5.06% 5,649,884 +1,768,091 +46% +$24.4M
MNTA
5
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$75.7M 4.92% +3,702,533 New +$75.7M
IMMU
6
DELISTED
Immunomedics Inc
IMMU
$73.8M 4.79% +3,119,778 New +$73.8M
MYOV
7
DELISTED
Myovant Sciences Ltd.
MYOV
$64.7M 4.2% 2,830,455 – –
IFRX icon
8
InflaRx
IFRX
$108M
$63.4M 4.12% 1,967,148 +346,495 +21% +$11.2M
TGTX icon
9
TG Therapeutics
TGTX
$4.65B
$56.3M 3.65% 4,278,796 +1,806,452 +73% +$23.8M
SAGE
10
DELISTED
Sage Therapeutics
SAGE
$54.9M 3.57% 350,933 -2,200 -0.6% -$344K
ZGNX
11
DELISTED
Zogenix, Inc.
ZGNX
$50.6M 3.29% 1,145,268 – –
RYTM icon
12
Rhythm Pharmaceuticals
RYTM
$6.85B
$48.2M 3.13% +1,541,743 New +$48.2M
DRNA
13
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$48.2M 3.13% 3,933,489 – –
EIDX
14
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$44M 2.86% +2,162,671 New +$44M
BCRX icon
15
BioCryst Pharmaceuticals
BCRX
$1.74B
$40M 2.6% 6,984,692 – –
RARX
16
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$38.3M 2.49% 3,851,808 – –
KALA icon
17
KALA BIO
KALA
$78.8M
$29M 1.88% 2,113,236 – –
APLS icon
18
Apellis Pharmaceuticals
APLS
$3.48B
$19.8M 1.29% 900,000 – –
CLSD icon
19
Clearside Biomedical
CLSD
$28.9M
$16.3M 1.06% 1,525,000 – –
SCPH icon
20
scPharmaceuticals
SCPH
$295M
$16.2M 1.05% 2,857,143 – –
IOVA icon
21
Iovance Biotherapeutics
IOVA
$807M
$14.4M 0.93% 1,121,153 +462,094 +70% +$5.91M
KALV icon
22
KalVista Pharmaceuticals
KALV
$678M
$11.7M 0.76% 1,441,070 – –
AVEO
23
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$11.4M 0.74% 5,062,759 – –
SPRO icon
24
Spero Therapeutics
SPRO
$116M
$10.9M 0.71% 741,647 – –
CBIO
25
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$4.09M 0.27% 253,547 – –
1
2